Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Lantheus (LNTH)

Lantheus Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LNTH
DateTimeSourceHeadlineSymbolCompany
15/05/202422:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
15/05/202421:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
15/05/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
15/05/202421:30GlobeNewswire Inc.Lantheus Announces Executive Appointments to Accelerate InnovationNASDAQ:LNTHLantheus Holdings Inc
13/05/202422:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/05/202422:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/05/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/05/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/05/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
13/05/202416:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
02/05/202412:00GlobeNewswire Inc.Lantheus Reports First Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
18/04/202413:00GlobeNewswire Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
11/03/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
07/03/202415:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202401:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202401:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202401:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202401:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202401:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
06/03/202400:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
05/03/202413:30GlobeNewswire Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:LNTHLantheus Holdings Inc
04/03/202422:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
04/03/202413:30GlobeNewswire Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric PatientsNASDAQ:LNTHLantheus Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:LNTH